Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenpu Penyankeli for chronic pelvic pain after pelvic inflammatory disease
CTR20181703Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Sep 2018
- Countries
- 1
01
Overview
A Phase 2 trial of Shenpu Penyanke Granules in Pelviabdominal infection, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Sep 2018; status: completed.
02
Drugs
Shenpu Penyanke Granules
03
Conditions
Pelviabdominal infection
Beyond the preview
Go deeper on CTR20181703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181703.